Akanda Corp. Announces Closing of the Sale of RPK to Somai

London, United Kingdom–(Newsfile Corp. – April 11, 2024) – On April 1, 2024, Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”), an international medical cannabis company, completed the transaction with SOMAÍ Pharmaceuticals Ltd. (the “Buyer”) for the sale of RPK, its indirect wholly-owned Portuguese subsidiary. Pursuant to the provisions set forth in the definitive share purchase […]

Go to Source

Powered by WPeMatico